The serum concentration of ET-1 in subjects with hypertension (P = 0.001) (Fig. 2b), central obesity (P = 0.006) (Fig. 2c), and high fasting blood glucose (P = 0.03) (Fig. 2f) are significantly higher than those without. Here, EDN1 is linked to Abdominal obesity.